S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)

Swedish Orphan Biovitrum AB (publ) (BIOVF) Earnings Date, Estimates & Call Transcripts

$23.75
0.00 (0.00%)
(As of 03/1/2024 ET)

Earnings Summary

Latest
Earnings Date
Feb. 8Estimated
Actual EPS
(Feb. 8)
$0.30 Missed By -$0.26
Consensus EPS
(Feb. 8)
$0.56
Skip Charts & View Estimated and Actual Earnings Data

BIOVF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIOVF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BIOVF Earnings Date and Information

Swedish Orphan Biovitrum AB (publ) last posted its quarterly earnings results on February 8th, 2024. The reported $0.30 earnings per share for the quarter, missing the consensus estimate of $0.56 by $0.26. The company earned $643.39 million during the quarter, compared to analysts' expectations of $668.74 million. Swedish Orphan Biovitrum AB (publ) has generated $0.72 earnings per share over the last year ($0.72 diluted earnings per share) and currently has a price-to-earnings ratio of 33.0.

Swedish Orphan Biovitrum AB (publ) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/8/2024Q4 2023$0.56$0.30($0.26)$0.32$668.74 million$643.39 million
10/30/2023Q3 2023$0.09$0.05($0.04)$0.07$443.96 million$478.11 million
7/18/2023Q2 2023$0.11$0.14+$0.03$0.21$397.52 million$463.04 million
4/27/2023Q1 2023$0.22$0.34+$0.12$0.34$475.12 million$501.59 million
2/8/2023Q4 2022$0.44$0.43($0.01)$0.43$481.32 million$559.09 million
10/27/2022Q3 2022$0.12$0.14+$0.02$0.14$388.40 million$379.63 million
7/19/2022Q2 2022$0.08$0.09+$0.01$0.09$356.60 million$394.40 million
4/28/2022Q1 2022-$0.39+$0.39$0.58-$527.32 million
2/10/2022Q4 2021-$0.47+$0.47$0.47-$552.91 million
10/22/2021Q3 2021-$0.18+$0.18$0.18-$434.97 million
7/21/2021Q2 2021$0.14$0.11($0.03)$0.11$337.20 million$381.44 million
5/4/2021Q1 2021$0.31$0.28($0.03)$0.28$450.00 million$436.23 million












Swedish Orphan Biovitrum AB (publ) Earnings - Frequently Asked Questions

When did Swedish Orphan Biovitrum AB (publ) announce their last quarterly earnings?

Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) last announced its quarterly earning data on Thursday, February 8, 2024. Learn more on BIOVF's earnings history.

Did Swedish Orphan Biovitrum AB (publ) beat their earnings estimates last quarter?

In the previous quarter, Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) missed the analysts' consensus estimate of $0.56 by $0.26 with a reported earnings per share (EPS) of $0.30. Learn more on analysts' earnings estimate vs. BIOVF's actual earnings.

How much revenue does Swedish Orphan Biovitrum AB (publ) generate each year?

Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) has a recorded annual revenue of $2.09 billion.

How much profit does Swedish Orphan Biovitrum AB (publ) generate each year?

Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) has a recorded net income of $227.10 million. BIOVF has generated $0.72 earnings per share over the last four quarters.

What is Swedish Orphan Biovitrum AB (publ)'s price-to-earnings ratio?

Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) has a trailing price-to-earnings ratio of 32.99.


More Earnings Resources from MarketBeat

This page (OTCMKTS:BIOVF) was last updated on 3/2/2024 by MarketBeat.com Staff